606
Participants
Start Date
December 23, 2020
Primary Completion Date
March 31, 2021
Study Completion Date
February 6, 2022
Anakinra
Standard-of-care and anakinra. Anakinra is injected subcutaneously as 100 mg once daily for 10 days
Placebo
Standard-of-care and placebo. Placebo is injected subcutaneously once daily for 10 days
2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupoli
10th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens
1st Department of Internal Medicine, AMALIA FLEMING Prefecture General Hospital of Melissia, Athens
1st Department of Internal Medicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens
1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens
1st Department of Internal Medicine, General Hospital of Nea Ionia CONSTANTOPOULIO-PATISION, Athens
1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens
1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens
1st University Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens
2nd Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens
2nd Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens
2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens
3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens
3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens
4th Department of Internal Medicine, ATTIKON University General Hospital, Athens
4th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens
5th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens
COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Athens
Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens
Department of COVID-19, Evangelismos General Hospital, Athens
Department of Internal Medicine, General Hospital of Athens Elpis, Athens
• 1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens
• Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens
Department of Pulmonary Medicine, General Hospital of Kerkyra, Corfu
1st Department of Internal Medicine, General University Hospital of Ioannina, Ioannina
Department of Internal Medicine, University General Hospital of Larissa,, Larissa
Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Pátrai
2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus
1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloniki
1st Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloniki
2nd Department of Propedeutic Medicine, Ippokrateion University General Hospital of Thessaloniki, Thessaloniki
3rd University Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloniki
Dipartimento di Medicina Dipartimento di Malattie Infettive, ASST Spedali civili, Brescia
Unità Operativa Clinica Malattie Infettive, Ospedale Policlinico San Martino, Genova
Dipartimento di Medicina Interna, Istituto Clinico Humanitas, Milan
Medicina Interna, Reumatologia, Immunologia, IRCCS San Raffaele, Milan
Dipartimento di Malattie Infettive e Tropicali e Microbiologia, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar
Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose, IRCCS Lazzaro Spallanzani, Roma
Dipartimento Scienze di laboratorio e infettivologiche, Policlinico Universitario Agostino Gemelli, Roma
Dipartimento di Malattie infettive e tropicali-Università dell'Insubria, ASST dei Sette Laghi, Varese
Hellenic Institute for the Study of Sepsis
OTHER